2944
J. Am. Chem. Soc. 2000, 122, 2944-2945
Communications to the Editor
Scheme 1. Synthesis of 5-Vinyloxazolidinones 1
Enantioselective Synthesis of
3,6-Dihydro-1H-pyridin-2-ones: Unexpected
Regioselectivity in the Palladium-Catalyzed
Decarboxylative Carbonylation of
5-Vinyloxazolidin-2-ones
Julian G. Knight,*,† Simon W. Ainge,† Andrew M. Harm,†
Simon J. Harwood,† Haydn I. Maughan,† Duncan R. Armour,‡
David M. Hollinshead,§ and Albert A. Jaxa-Chamiec‡
Department of Chemistry, Bedson Building
Newcastle UniVersity
Newcastle upon Tyne, NE1 7RU, UK
GlaxoWellcome
Medicines Research Centre, Gunnels Wood Road
SteVenage, Hertfordshire, SG1 2NY, UK
Zeneca Pharmaceuticals, Mereside, Alderley Park
Macclesfield, Cheshire, SK10 4TG, UK
and five-membered lactams by decarboxylative carbonylation of
6-vinyltetrahydro-2H-1,3-oxazin-2-ones.13
Since the decarboxylative carbonylation of vinyltetrahydro-
oxazinones13 leads to ring contraction to form γ-lactams, we
envisaged a similar process leading from 5-vinyloxazolidin-2-
ones 1 to â-lactams. In this contribution we report that palladium-
catalyzed decarboxylative carbonylation of amino acid-derived
5-vinyloxazolidin-2-ones does not give the expected â-lactams.
Instead, the corresponding δ-lactams, 3,6-dihydro-1H-pyridin-2-
ones, are formed.
ReceiVed NoVember 3, 1999
Transition metal catalyzed carbonylation of organic substrates
has proved an important method for the synthesis of carbon-
carbon and carbon-heteroatom bonds.1 The synthesis of â-lactams
by transition metal catalyzed processes is well documented2,3 and
has been accomplished by the carbonylation of aziridines,4
2-bromoallylamines,5 propargylamines,6 4-amino-2-alkynyl car-
bonates,7 and allyl phosphates in the presence of imines.8
Transition metal catalyzed carbonylative syntheses of lactams with
ring sizes larger than 4 include: benzo-fused five-, six-, and seven-
membered lactams by cyclocarbonylation of 2-aminostyrenes and
2-allylanilines;9 four-, five-, six-, and seven-membered R,â-
unsaturated lactams from amino vinyl-halides10a,b and -triflates;10c
five-, and six-membered lactams by hydrocarbonylation of amino-
alkenes11a,b and -alkynes;11c five-, and six-membered lactams by
carbonylative ring-expansion of azetidines12a and pyrrolidines;12b
The required 5-vinyloxazolidin-2-ones 1 were synthesized from
the corresponding R-amino aldehydes14 2 (R2 ) H) or ketone 2d
(R1 ) i-Pr, R2 ) Me) (Scheme 1). Aldehydes 2 (R2 ) H) were
obtained by Swern oxidation15 of the corresponding N-BOC
protected R-amino alcohols. Ketone 2d (R1 ) i-Pr, R2 ) Me)
was prepared by the addition of MeMgBr to the corresponding
Weinreb amide.16 Grignard additions to 2 proceeded, as ex-
pected,14 with low diastereoselectivity to produce the alcohols 3
as 1-5:1 mixtures of diastereoisomers which were cyclized to
the oxazolidinones 1 by treatment with sodium hydride.
Attempted carbonylation of 1a under the conditions reported
for ring-expansion of aziridines4c (20 mol % Pd2(dba)3‚CHCl3,
160 mol % PPh3, 1 atm CO, rt, C6H6) gave complete recovery of
starting material. Indeed, we were unable to find any catalyst/
solvent system which would enable the carbonylation of vinyl-
oxazolidinones to proceed at 1 atm of CO. Even at higher
pressures (up to 60 atm) the carbonylation was unsuccessful in
aprotic solvents such as THF, DMF, and MeCN. However,
carbonylation was successful using Pd(OAc)2(PPh3)2 (5 mol %)
at a CO pressure of 65 atm in a protic solvent, ethanol.17 The
product from this reaction was not the expected â-lactam but the
δ-lactam 4a. The reaction was not catalyzed by either Pd(OAc)2
or PPh3 alone. Table 1 shows that this reaction is successful for
a range of oxazolidinones providing δ-lactams in good to excellent
yields.18 The reaction tolerates substitution at C-5 (R2 ) Me, see
entry for 1g) and on the central carbon of the allyl system (R3 )
Me, entries for 1d-f), but fails in the case of the terminally
disubstituted vinyl derivative 1h (R4 ) Me) probably due to the
requirement for carbonylation to form a quaternary center in this
case. Comparison of 4a and 4g with ent-4a and ent-4g (prepared
† Newcastle University.
‡ GlaxoWellcome.
§ Zeneca Pharmaceuticals.
(1) Colquhoun, H. M.; Thompson, D. G.; Twigg, M. V. In Carbonylation;
Plenum Press: New York, 1991; pp 191-203.
(2) Barrett, A. G. M.; Sturgess, M. A. Tetrahedron 1988, 44, 5615-5652.
(3) Khumtaveeporn, K.; Alper, H. Acc. Chem. Res. 1995, 28, 414-422.
(4) (a) Piotti, M. E.; Alper, H. J. Am. Chem. Soc. 1996, 118, 111-116. (b)
Calet, S.; Urso, F.; Alper, H. J. Am. Chem. Soc. 1989, 111, 931-934. (c)
Spears, G. W.; Nakanishi, K.; Ohfune, Y. Synlett 1991, 91-92. (d) Tanner,
D.; Somfai, P. Bioorg. Med. Chem. Lett. 1993, 3, 2415-2418.
(5) Mori, M.; Chiba, K.; Okita, M.; Kayo, I.; Ban, Y. Tetrahedron 1985,
41, 375-385.
(6) (a) Bonardi, A.; Costa, M.; Gabriele, B.; Salerno, G.; Chiusoli, G. P.
Tetrahedron Lett. 1995, 36, 7495-7498. (b) Matsuda, I.; Sakakibara, J.;
Nagashima, H. Tetrahedron Lett. 1991, 32, 7431-7434.
(7) Mandai, T.; Ryoden, K.; Kawada, M.; Tsuji, J. Tetrahedron Lett. 1991,
32, 7683-7686.
(8) (a) Torii, S.; Okumoto, H.; Sadakane, M.; Hai, A. K. M. A.; Tanaka,
H. Tetrahedron Lett. 1993, 34, 6553-6556. (b) Zhou, Z.; Alper, H. J. Org.
Chem. 1996, 61, 1256-1260.
(9) El Ali, B.; Okuro, K.; Vasapollo, G.; Alper, H. J. Am. Chem. Soc. 1996,
118, 4264-4270.
(10) (a) Mori, M.; Washioka, Y.; Urayama, T.; Yoshiura, K.; Chiba, K.;
Ban, Y. J. Org. Chem. 1983, 48, 4058-4067. (b) Cope´ret, C.; Ma, S.; Sugihara,
T.; Negishi, E.-I. Tetrahedron 1996, 52, 11529-11544. (c) Crisp, G. T.; Meyer,
A. G. Tetrahedron, 1995, 51, 5585-5596.
(13) Bando, T.; Tanaka, S.; Fugami, K.; Yoshida, Z.-I.; Tamaru, Y. Bull.
Chem. Soc. Jpn 1992, 65, 97-110.
(14) Jurczak, J.; Golebiowski, A. Chem. ReV. 1989, 89, 149-164.
(15) Mancuso, A. J.; Huang, S.-L.; Swern, D. J. Org. Chem. 1978, 43, 3,
2480-2482.
(11) (a) Krafft, M. E.; Wilson, L. J.; Onan, K. D. Tetrahedron Lett. 1988,
29, 6421. (b) Zhou, J. Q.; Alper, H. J. Org. Chem. 1992, 57, 3328-3331. (c)
Campi, E. M.; Chong, J. M.; Jackson, W. R.; van der Schoot, M. Tetrahedron
1994, 50, 2533-2542.
(16) Nahm, S.; Weinreb, S. M. Tetrahedron Lett. 1981, 22, 3815.
(17) These conditions are similar to those reported by Bando for the
decarboxylative carbonylation of vinyloxazinones.13
(12) (a) Roberto, D.; Alper, H. J. Am. Chem. Soc. 1989, 111, 7539. (b)
Wang, M. D.; Alper, H. J. Am. Chem. Soc., 1992, 114, 7018.
(18) See the Supporting Information for experimental procedures.
10.1021/ja993897c CCC: $19.00 © 2000 American Chemical Society
Published on Web 03/10/2000